Senzime develops unique patient-oriented monitoring systems that make it possible to assess patients' biochemical and physiological processes before, during and after surgery. The solutions are designed to ensure maximum patient benefit, reduce complications and decrease healthcare costs. The company's shares are listed on Nasdaq First North (ticker SEZI).
TetraGraph-The Next Generation TOF-monitor. The arm can be tucked under surgical drapes, no thumb access required. It requires less than 30s start-up with no calibration needed. Ease of use, with single-use electrosensors and no cross-contamination. Precise and reliable information based on EMG-technique.